METHOD OF TREATING CATARRHAL COMPLICATIONS OF UPPER AIRWAYS IN ACUTE RESPIRATORY VIRAL INFECTIONS IN CHILDREN Russian patent published in 2019 - IPC A61N5/06 A61K38/21 A61P11/00 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to otorhinolaryngology, and can be used in treating acute respiratory viral infections (ARVI) in children. Method involves exposing the oral and pharyngeal mucosa to a blue light source with underlying drug therapy. Surface of the nasal mucosa is pre-dried for 5–10 seconds with dry air, then an ointment containing interferon-alpha-2 is applied intranasal. That is followed by exposing the projections of the nasal wings and maxillary sinuses, frontal, occipital, subclavian areas from both sides by irradiating narrow-band optical radiation at wave length 470 nm in radiation dose 1.5–2 J/cm² duration of 2 minutes per field with 7-day course.

EFFECT: use of the invention allows reducing the length of treatment of catarrhal complications of ARVI, preventing the recurrent course of the inflammatory process on the upper respiratory tract mucosa, recovering the local immunity indices.

1 cl, 4 dwg, 4 tbl, 3 ex